Trial Profile
Effectiveness of Vonoprazan in patients treated with post-ESD gastric ulcer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Jun 2021
Price :
$35
*
At a glance
- Drugs Vonoprazan (Primary) ; Lansoprazole; Lansoprazole
- Indications Gastric ulcer
- Focus Therapeutic Use
- 22 May 2021 Primary endpoint (healing rate of the artificial ulcer at 4 weeks after ESD) has not been met according to results published in the BMC Gastroenterology
- 22 May 2021 Results evaluating the effectiveness of vonoprazan in artificial ulcer healing following ESD published in the BMC Gastroenterology
- 21 Jul 2020 Status changed from not yet recruiting to completed.